cerca CERCA
Martedì 24 Maggio 2022
Aggiornato: 08:15
Temi caldi

cambridge

Gb, 42 milioni di dollari per sviluppare vaccino Covid contro tutte le varianti

Un vaccino 'pan-coronavirus' in grado di essere efficace contro tutte le varianti. DioSynVax, azienda biotecnologica dell'Università di Cambridge, riceverà 42 milioni di dollari per sviluppare un candidato vaccino in grado di fornire protezione contro le varianti, esistenti e future, di Sars-CoV-2 e altri importanti coronavirus, compresi quelli che causano Sars e Mers. Lo annuncia l'Università di Cambridge sul proprio sito. A finanziare lo sviluppo del nuovo vaccino e gli studi di Fase 1 e 2 è la...

comunicato stampa

Standigm Expands Global Footprints with New Office in Cambridge, UK

SEOUL, South Korea, Aug. 20, 2021 /PRNewswire/ -- Standigm, a leading workflow AI drug discovery company, today announced the opening of a new office in Cambridge, United Kingdom ("UK"), to accommodate the company's rapid growth in the European market.

Drawbridge Health partners with University of Cambridge Researchers for use of OneDraw™ Blood Collection Device in COVID-19 and Other Clinical Studies

MENLO PARK, Calif., Dec. 3, 2020 /PRNewswire/ -- Drawbridge Health and the Medical Research Council (MRC) Epidemiology Unit, University of Cambridge (UK) today announced the use of the OneDraw™ Blood Collection Device1 for remote blood sample collection in a large-scale surveillance study currently being conducted to assess the prevalence of previous infection with COVID-19. Because of the restrictions the pandemic has created for normal contact between researchers and research volunteers, remote...

Sai Life Sciences expands suite of cellular analysis platforms in Cambridge, MA

CAMBRIDGE, Mass. and HYDERABAD, India, Sept. 10, 2020 /PRNewswire/ --  Sai Life Sciences, one of India's fastest growing Contract Development & Manufacturing Organizations (CDMOs), today announced the addition of state-of-the-art cellular analysis platforms at its Discovery Biology facility in Cambridge, Massachusetts, USA. 

ora in
Prima pagina
articoli
in Evidenza